Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioCardia Inc.

    NASDAQ: BCDAW · Real-Time Price · USD
    0.01
    0.00 (58.73%)
    At close: Aug 02, 2024, 8:00 PM

    BioCardia Statistics

    Share Statistics

    BioCardia has 1.66M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 1.66M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 0.38%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.75 and the forward PE ratio is null. BioCardia's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.75

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 103.13

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 7.15

    P/FCF Ratio

    n/a
    		 -0.74

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for BioCardia.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.14.

    Current Ratio

    n/a
    		 1.13

    Quick Ratio

    n/a
    		 1.13

    Debt / Equity

    n/a
    		 1.14

    Debt / EBITDA

    n/a
    		 -0.12

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $3,625

    Profits Per Employee

    n/a
    		 $-496,625

    Employee Count

    n/a
    		 16

    Asset Turnover

    n/a
    		 0.02

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 1.36, so BioCardia's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.36

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.02

    200-Day Moving Average

    n/a
    		 0.39

    Relative Strength Index (RSI)

    n/a
    		 39.09

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    In the last 12 months, BioCardia had revenue of 58K and earned -7.95M in profits. Earnings per share was -2.9.

    Revenue

    n/a
    		 58K

    Gross Profit

    n/a
    		 58K

    Operating Income

    n/a
    		 -8M

    Net Income

    n/a
    		 -7.95M

    EBITDA

    n/a
    		 -7.93M

    EBIT

    n/a
    		 -8M

    Earnings Per Share (EPS)

    n/a
    		 -2.9
    Full Income Statement

    Balance Sheet

    The company has 2.37M in cash and 951K in debt, giving a net cash position of 1.42M.

    Cash & Cash Equivalents

    n/a
    		 2.37M

    Total Debt

    n/a
    		 951K

    Net Cash

    n/a
    		 1.42M

    Retained Earnings

    n/a
    		 -160.12M

    Total Assets

    n/a
    		 3.72M

    Working Capital

    n/a
    		 301K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.03M and capital expenditures -6K, giving a free cash flow of -8.03M.

    Operating Cash Flow

    n/a
    		 -8.03M

    Capital Expenditures

    n/a
    		 -6K

    Free Cash Flow

    n/a
    		 -8.03M

    FCF Per Share

    n/a
    		 -2.93
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -13794.83% and -13700%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -13794.83%

    Pretax Margin

    n/a
    		 -13700%

    Profit Margin

    n/a
    		 -13700%

    EBITDA Margin

    n/a
    		 -13679.31%

    EBIT Margin

    n/a
    		 -13794.83%

    FCF Margin

    n/a
    		 -13848.28%

    Dividends & Yields

    BCDAW does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BCDAW.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -67.17

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist